Herborium Group, Inc. to Make Major Announcement on April 6th 2012 Regarding Its Business, 2012 Expansion Revenue Streams and Launch of New Market Ventures

TEANECK, N.J., March 16, 2012 /PRNewswire/ -- Herborium Group, Inc. (HBRM.PK) announced today that it will make a major announcement on April 6, 2012 regarding its business 2012 expansion and new  revenue streams through adding new Market Venture to  Herborium Group, Inc. This new venture with over $150 billion market potential may be regarded as one of the most significant developments in the Company's  history and is expected  to have a defining impact on its  growth.

Dr Agnes Olszewski, CEO of Herborium Group, Inc. stated: "we are very excited to confirm that the Company is getting geared up for expansion in all avenues of our products with substantial new revenue streams and new markets ventures soon in place. We understand the importance of natural approach to both health and quality of life issues  and our initiative has always been and always will focus on the world of Natural Medicine, Wellness and Quality of Life products which have  been growing at an unprecedented pace. The Company is now ready for significant growth."

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com. 

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com